Los Angeles Capital Management’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
Other funds holding BVS
EWM
JIC
NCM
VCM
RA
VPM
Los Angeles Capital Management's BVS Position: Q1 2026 in Review
Los Angeles Capital Management reduced its Bioventus (BVS) stake by 100% in Q1 2026, selling an estimated $569K and leaving 70 shares worth $639. The position accounts for ﹤0.01% of the portfolio, ranked #2356.
Los Angeles Capital Management first reported a position in BVS in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.71M in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.
- Los Angeles Capital Management held 70 shares of Bioventus worth $639 as of Q1 2026.
- Los Angeles Capital Management sold 67,898 Bioventus shares in Q1 2026, an estimated $569K.
- Bioventus made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #2356 holding.
- Los Angeles Capital Management first reported a position in Bioventus in Q4 2021 and has held it in 9 quarters since.
- Los Angeles Capital Management's Bioventus position peaked at $1.71M in Q3 2024.
- 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.